[ad_1]
Health News Saturday, February 9, 2019
Source: ghananewsagency.org
2019-02-09
The FDA reiterated its commitment to the mandate to ensure public health
The Food and Drugs Authority (FDA) has informed the public that it has not registered the Lybrel and Seasonique contraceptive pills for use in the country because they circulated on social media.
In a statement signed by Ms. Delese Darko, the executive director of the FDA, and published in Accra on Thursday, she said she has not received any reports of suspected adverse reactions mentioned in social media.
He said health facilities or practitioners and the general public had not reported to the FDA in Ghana.
As a result, the AMF urges the public to consult a family planning health professional before starting to use a birth control method.
Although the FDA has not confirmed the presence of both products on the market, it should warn the FDA of any issues related to the above topic or any other issue related to public health and safety. his contacts.
The FDA has reaffirmed its commitment to the mandate to ensure the health and safety of the public with respect to all regulated products.
Source link
